Drugs Made In America Acquisition Cash Flow Statement (2025) | DMAAR

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) 1.25M2.29M2.18M0.21M
Cash from Operations (Quarter) -0.25M-0.11M-0.06M-0.13M
Change in Working Capital
Change in Accured Expenses (Quarter) 0.06M0.01M0.16M-0.08M
Investing Activities
Cash from Investing Activities (Quarter) -231.15M
Financing Activities
Other financing activities (Quarter) 3.20M
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) 0.90M
Misc.
Cash from Financing Activities (Quarter) 231.40M0.11M0.06M0.13M
Change in Cash (Quarter) -428.00-101.00-105.000.01M
Free Cash Flow (Quarter) -0.25M-0.11M-0.06M-0.13M
Net Cash Flow (Quarter) -428.00-101.00-105.000.01M